Candida albicans mycofilms support Staphylococcus aureus colonization and enhances miconazole resistance in dual-species interactions

Frontiers in Microbiology

Volumn 8, Issue FEB, 2017, Pages

  Kean, Ryan ^a,b   Rajendran, Ranjith ^a   Haggarty, Jennifer ^c   Townsend, Eleanor M ^a,b   Short, Bryn ^a,d   Burgess, Karl E ^c   Lang, Sue ^d   Millington, Owain ^e   Mackay, William G ^b   Williams, Craig ^b   Ramage, Gordon ^a  

^a GLASGOW DENTAL HOSPITAL AND SCHOOL   (United Kingdom)

^b UNIVERSITY OF THE WEST OF SCOTLAND   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

^e UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Biofilm; Candida albicans; Extracellular DNA; Miconazole; Staphylococcus aureus

Indexed keywords

CRYSTAL VIOLET; MICONAZOLE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL SURVIVAL; BIOFILM; CANDIDA ALBICANS; CELL ADHESION ASSAY; CONFOCAL LASER SCANNING MICROSCOPY; CONTROLLED STUDY; DRUG EFFICACY; EXTRACELLULAR MATRIX; GALLERIA MELLONELLA; LARVA; LIMIT OF QUANTITATION; MICROBIAL BIOMASS; MICROBIAL VIABILITY; MICROTITER PLATE ASSAY; MINIMUM INHIBITORY CONCENTRATION; MIXED INFECTION; MORTALITY RATE; NONHUMAN; ORGANISMAL INTERACTION; PATHOGEN LOAD; REAL TIME POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY; STAPHYLOCOCCUS AUREUS;

EID: 85014508325     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2017.00258     Document Type: Article

References (52)

1. Alves, C. T., Silva, S., Pereira, L., Williams, D. W., Azeredo, J., and Henriques, M. (2014). Effect of progesterone on Candida albicans vaginal pathogenicity. Int. J. Med. Microbiol. 304, 1011-1017. doi: 10.1016/j.ijmm.2014.07.004.
2. Beenken, K. E., Blevins, J. S., and Smeltzer, M. S. (2003). Mutation of sarA in Staphylococcus aureus limits biofilm formation. Infect. Immun. 71, 4206-4211. doi: 10.1128/IAI.71.7.4206-4211.2003.
3. Boyen, F., Verstappen, K. M., De Bock, M., Duim, B., Weese, J. S., Schwarz, S., et al. (2012). In vitro antimicrobial activity of miconazole and polymyxin B against canine meticillin-resistant Staphylococcus aureus and meticillin-resistant Staphylococcus pseudintermedius isolates. Vet. Dermatol. 23, e70. doi: 10.1111/j.1365-3164.2012.01040.x.
4. Carlson, E. (1983). Effect of strain of Staphylococcus aureus on synergism with Candida albicans resulting in mouse mortality and morbidity. Infect. Immun. 42, 285-292.
5. CLSI (2012). Reference Method for Broth Dilution Antifungal Susceptibility Testing Of Yeasts, Approved Standard-CLSI Document M27-A3, 3rd Edn. Wayne, PA: Clinical & Laboratory Standards Institute.
6. De Brucker, K., Tan, Y., Vints, K., De Cremer, K., Braem, A., Verstraeten, N., et al. (2015). Fungal beta-1,3-glucan increases ofloxacin tolerance of Escherichia coli in a polymicrobial E. coli/Candida albicans biofilm. Antimicrob. Agents Chemother. 59, 3052-3058. doi: 10.1128/AAC.04650-14.
7. Duthie, E. S., and Lorenz, L. L. (1952). Staphylococcal coagulase; mode of action and antigenicity. J. Gen. Microbiol. 6, 95-107. doi: 10.1099/00221287-6-1-2-95.
8. Erlandsen, S. L., Kristich, C. J., Dunny, G. M., and Wells, C. L. (2004). High-resolution visualization of the microbial glycocalyx with low-voltage scanning electron microscopy: dependence on cationic dyes. J. Histochem. Cytochem. 52, 1427-1435. doi: 10.1369/jhc.4A6428.2004.
9. Fonzi, W. A., and Irwin, M. Y. (1993). Isogenic strain construction and gene mapping in Candida albicans. Genetics 134, 717-728.
10. Frederiksen, B., Pressler, T., Hansen, A., Koch, C., and Hoiby, N. (2006). Effect of aerosolized rhDNase (Pulmozyme) on pulmonary colonization in patients with cystic fibrosis. Acta Paediatr. 95, 1070-1074. doi: 10.1080/08035250600752466.
11. Gibson, J., Sood, A., and Hogan, D. A. (2009). Pseudomonas aeruginosa-Candida albicans interactions: localization and fungal toxicity of a phenazine derivative. Appl. Environ. Microbiol. 75, 504-513. doi: 10.1128/AEM.01037-08.
12. Harriott, M. M., and Noverr, M. C. (2009). Candida albicans and Staphylococcus aureus form polymicrobial biofilms: effects on antimicrobial resistance. Antimicrob. Agents Chemother. 53, 3914-3922. doi: 10.1128/AAC.00657-09.
13. Jabra-Rizk, M. A., Meiller, T. F., James, C. E., and Shirtliff, M. E. (2006). Effect of farnesol on Staphylococcus aureus biofilm formation and antimicrobial susceptibility. Antimicrob. Agents Chemother. 50, 1463-1469. doi: 10.1128/AAC.50.4.1463-1469.2006.
14. Kart, D., Tavernier, S., Van Acker, H., Nelis, H. J., and Coenye, T. (2014). Activity of disinfectants against multispecies biofilms formed by Staphylococcus aureus, Candida albicans and Pseudomonas aeruginosa. Biofouling 30, 377-383. doi: 10.1080/08927014.2013.878333.
15. Klotz, S. A., Chasin, B. S., Powell, B., Gaur, N. K., and Lipke, P. N. (2007). Polymicrobial bloodstream infections involving Candida species: analysis of patients and review of the literature. Diagn. Microbiol. Infect. Dis. 59, 401-406. doi: 10.1016/j.diagmicrobio.2007.07.001.
16. Kobayashi, D., Kondo, K., Uehara, N., Otokozawa, S., Tsuji, N., Yagihashi, A., et al. (2002). Endogenous reactive oxygen species is an important mediator of miconazole antifungal effect. Antimicrob. Agents Chemother. 46, 3113-3117. doi: 10.1128/AAC.46.10.3113-3117.2002.
17. Kong, E. F., Kucharikova, S., Van Dijck, P., Peters, B. M., Shirtliff, M. E., and Jabra-Rizk, M. A. (2015). Clinical Implications of Oral Candidiasis: host tissue damage and disseminated bacterial disease. Infect. Immun. 83, 604-613. doi: 10.1128/IAI.02843-14.
18. Kong, E. F., Tsui, C., Kucharikova, S., Andes, D., Van Dijck, P., and Jabra-Rizk, M. A. (2016). Commensal Protection of Staphylococcus aureus against antimicrobials by Candida albicans biofilm matrix. MBio 7, e01365-16. doi: 10.1128/mBio.01365-16.
19. Kuroda, M., Nagasaki, S., Ito, R., and Ohta, T. (2007). Sesquiterpene farnesol as a competitive inhibitor of lipase activity of Staphylococcus aureus. FEMS Microbiol. Lett. 273, 28-34. doi: 10.1111/j.1574-6968.2007.00772.x.
20. Lin, Y. J., Alsad, L., Vogel, F., Koppar, S., Nevarez, L., Auguste, F., et al. (2013). Interactions between Candida albicans and Staphylococcus aureus within mixed species biofilms. BIOS 84, 30-39. doi: 10.1893/0005-3155-84.1.30.
21. Lister, J. L., and Horswill, A. R. (2014). Staphylococcus aureus biofilms: recent developments in biofilm dispersal. Front. Cell Infect. Microbiol. 4:178. doi: 10.3389/fcimb.2014.00178.
22. Memmi, G., Nair, D. R., and Cheung, A. (2012). Role of ArlRS in autolysis in methicillin-sensitive and methicillin-resistant Staphylococcus aureus strains. J. Bacteriol. 194, 759-767. doi: 10.1128/JB.06261-11.
23. Nett, J., Lincoln, L., Marchillo, K., Massey, R., Holoyda, K., Hoff, B., et al. (2007). Putative role of beta-1,3 glucans in Candida albicans biofilm resistance. Antimicrob. Agents Chemother. 51, 510-520. doi: 10.1128/AAC.01056-06.
24. Nobre, L. S., Todorovic, S., Tavares, A. F., Oldfield, E., Hildebrandt, P., Teixeira, M., et al. (2010). Binding of azole antibiotics to Staphylococcus aureus flavohemoglobin increases intracellular oxidative stress. J. Bacteriol. 192, 1527-1533. doi: 10.1128/JB.01378-09.
25. O'Donnell, L. E., Smith, K., Williams, C., Nile, C. J., Lappin, D. F., Bradshaw, D., et al. (2016). Dentures are a reservoir for respiratory pathogens. J. Prosthodont. 25, 99-104. doi: 10.1111/jopr.12342.
26. Peleg, A. Y., Hogan, D. A., and Mylonakis, E. (2010). Medically important bacterial-fungal interactions. Nat. Rev. Microbiol. 8, 340-349. doi: 10.1038/nrmicro2313.
27. Peters, B. M., Jabra-Rizk, M. A., O'may, G. A., Costerton, J. W., and Shirtliff, M. E. (2012a). Polymicrobial interactions: impact on pathogenesis and human disease. Clin. Microbiol. Rev. 25, 193-213. doi: 10.1128/CMR.00013-11.
28. Peters, B. M., Jabra-Rizk, M. A., Scheper, M. A., Leid, J. G., Costerton, J. W., and Shirtliff, M. E. (2010). Microbial interactions and differential protein expression in Staphylococcus aureus-Candida albicans dual-species biofilms. FEMS Immunol. Med. Microbiol. 59, 493-503. doi: 10.1111/j.1574-695X.2010.00710.x.
29. Peters, B. M., and Noverr, M. C. (2013). Candida albicans-Staphylococcus aureus polymicrobial peritonitis modulates host innate immunity. Infect. Immun. 81, 2178-2189. doi: 10.1128/IAI.00265-13.
30. Peters, B. M., Ovchinnikova, E. S., Krom, B. P., Schlecht, L. M., Zhou, H., Hoyer, L. L., et al. (2012b). Staphylococcus aureus adherence to Candida albicans hyphae is mediated by the hyphal adhesin Als3p. Microbiology 158, 2975-2986. doi: 10.1099/mic.0.062109-0.
31. Pierce, C. G., Uppuluri, P., Tristan, A. R., Wormley, FL Jr., Mowat, E., Ramage, G., et al. (2008). A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat. Protoc. 3, 1494-1500. doi: 10.1038/nport.2008.141.
32. Rajendran, R., Borghi, E., Falleni, M., Perdoni, F., Tosi, D., Lappin, D. F., et al. (2015). Acetylcholine protects against Candida albicans infection by inhibiting biofilm formation and promoting hemocyte function in a Galleria mellonella infection model. Eukaryot. Cell 14, 834-844. doi: 10.1128/EC.00067-15.
33. Rajendran, R., May, A., Sherry, L., Kean, R., Williams, C., Jones, B. L., et al. (2016a). Integrating Candida albicans metabolism with biofilm heterogeneity by transcriptome mapping. Sci. Rep. 6:35436. doi: 10.1038/srep35436.
34. Rajendran, R., Sherry, L., Deshpande, A., Johnson, E. M., Hanson, M. F., Williams, C., et al. (2016b). A prospective surveillance study of candidaemia: epidemiology, risk factors, antifungal treatment and outcome in hospitalized patients. Front. Microbiol. 7:915. doi: 10.3389/fmicb.2016.00915.
35. Rajendran, R., Sherry, L., Lappin, D. F., Nile, C. J., Smith, K., Williams, C., et al. (2014). Extracellular DNA release confers heterogeneity in Candida albicans biofilm formation. BMC Microbiol. 14:303. doi: 10.1186/s12866-014-0303-6.
36. Ramage, G., Vande Walle, K., Wickes, B. L., and Lopez-Ribot, J. L. (2001). Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob. Agents Chemother. 45, 2475-2479. doi: 10.1128/AAC.45.9.2475-2479.2001.
37. Sancho, S., Artero, A., Zaragoza, R., Camarena, J. J., Gonzalez, R., and Nogueira, J. M. (2012). Impact of nosocomial polymicrobial bloodstream infections on the outcome in critically ill patients. Eur. J. Clin. Microbiol. Infect. Dis. 31, 1791-1796. doi: 10.1007/s10096-011-1503-8.
38. Sapaar, B., Nur, A., Hirota, K., Yumoto, H., Murakami, K., Amoh, T., et al. (2014). Effects of extracellular DNA from Candida albicans and pneumonia-related pathogens on Candida biofilm formation and hyphal transformation. J. Appl. Microbiol. 116, 1531-1542. doi: 10.1111/jam.12483.
39. Schlecht, L. M., Peters, B. M., Krom, B. P., Freiberg, J. A., Hansch, G. M., Filler, S. G., et al. (2015). Systemic Staphylococcus aureus infection mediated by Candida albicans hyphal invasion of mucosal tissue. Microbiology 161, 168-181. doi: 10.1099/mic.0.083485-0.
40. Sheppard, D. C., Yeaman, M. R., Welch, W. H., Phan, Q. T., Fu, Y., Ibrahim, A. S., et al. (2004). Functional and structural diversity in the Als protein family of Candida albicans. J. Biol. Chem. 279, 30480-30489. doi: 10.1074/jbc.M401929200.
41. Sherry, L., Lappin, G., O'donnell, L. E., Millhouse, E., Millington, O. R., Bradshaw, D. J., et al. (2016). Viable compositional analysis of an eleven species oral polymicrobial biofilm. Front. Microbiol. 7:912. doi: 10.3389/fmicb.2016.00912.
42. Sherry, L., Rajendran, R., Lappin, D. F., Borghi, E., Perdoni, F., Falleni, M., et al. (2014). Biofilms formed by Candida albicans bloodstream isolates display phenotypic and transcriptional heterogeneity that are associated with resistance and pathogenicity. BMC Microbiol. 14:182. doi: 10.1186/1471-2180-14-182.
43. Shine, W. E., Silvany, R., and Mcculley, J. P. (1993). Relation of cholesterol-stimulated Staphylococcus aureus growth to chronic blepharitis. Invest. Ophthalmol. Vis. Sci. 34, 2291-2296.
44. Smith, K., Perez, A., Ramage, G., Lappin, D., Gemmell, C. G., and Lang, S. (2008). Biofilm formation by Scottish clinical isolates of Staphylococcus aureus. J. Med. Microbiol. 57, 1018-1023. doi: 10.1099/jmm.0.2008/000968-0.
45. Spellberg, B., Ibrahim, A. S., Yeaman, M. R., Lin, L., Fu, Y., Avanesian, V., et al. (2008). The antifungal vaccine derived from the recombinant N terminus of Als3p protects mice against the bacterium Staphylococcus aureus. Infect. Immun. 76, 4574-4580. doi: 10.1128/IAI.00700-08.
46. Townsend, E., Sherry, L., Rajendran, R., Hansom, D., Butcher, J., Mackay, W. G., et al. (2016). Development and characterisation of a novel three-dimensional interkingdom wound biofilm model. Biofouling 32, 1259-1270. doi: 10.1080/08927014.2016.1252337.
47. Unnanuntana, A., Bonsignore, L., Shirtliff, M. E., and Greenfield, E. M. (2009). The effects of farnesol on Staphylococcus aureus biofilms and osteoblasts. An in vitro study. J. Bone Joint Surg. Am. 91, 2683-2692. doi: 10.2106/JBJS.H.01699.
48. Valenza, G., Tappe, D., Turnwald, D., Frosch, M., Konig, C., Hebestreit, H., et al. (2008). Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis. J. Cyst. Fibros. 7, 123-127. doi: 10.1016/j.jcf.2007.06.006.
49. Vanden Bossche, H., Marichal, P., Willemsens, G., Bellens, D., Gorrens, J., Roels, I., et al. (1990). Saperconazole: a selective inhibitor of the cytochrome P-450-dependent ergosterol synthesis in Candida albicans, Aspergillus fumigatus and Trichophyton mentagrophytes. Mycoses 33, 335-352.
50. Vandenbosch, D., Braeckmans, K., Nelis, H. J., and Coenye, T. (2010). Fungicidal activity of miconazole against Candida spp. biofilms. J. Antimicrob. Chemother. 65, 694-700. doi: 10.1093/jac/dkq019.
51. Weidj, S., Haggarty, J., Kean, R., Cojocariu, C. I., Silcock, P. J., Rajendran, R., et al. (2016). A novel targeted/untargeted GC-Orbitrap metabolomics methodology applied to Candida albicans and Staphylococcus aureus biofilms. Metabolomics 12, 189. doi: 10.1007/s11306-016-1134-2.
52. Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., and Edmond, M. B. (2004). Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39, 309-317. doi: 10.1086/421946.